What amount sold does Gaingels Respira 2022 LLC report in Form D filings?

The latest linked filings report $357K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Gaingels Respira 2022 LLC's most recent SEC filing?

Gaingels Respira 2022 LLC's most recent Form D filing was on 2022-07-07.

How many investors does Gaingels Respira 2022 LLC have?

The most recent Form D filing lists 25 investor(s).

What type of securities does Gaingels Respira 2022 LLC offer?

Gaingels Respira 2022 LLC's SEC Form D filings indicate equity offerings.

Gaingels Respira 2022 LLC

CIK: 0001926447·Other·BURLINGTON, VT·Limited Liability Company·Founded 2022

Reported Sold

$356,982

Total Filings

Identified Offerings

Last Filed

Jul 7, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Jul 7, 2022Form D — New notice

Reported sold: $356,982 · Target: $356,982

Rule 506(b)·25 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$356,982

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

David Beatty

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 7, 2022	New	$356,982	$356,982	25

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Gaingels Mushroom LLC

Other

Offering target: $221,590

Filed May 11, 2026